SCHEMBL1869756

SCHEMBL1869756

CCCCS(=O)(=O)NCO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA12 O43570 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
RELA Q04206 4/20 0.41
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
NPC1 O15118 1/20 0.38
S1PR2 O95136 1/20 0.38
S1PR4 O95977 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
XBP1 P17861 1/20 0.38
S1PR1 P21453 1/20 0.38
MAPK1 P28482 1/20 0.38
AGTR1 P30556 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10897013 0.85 MMP8 (0.44) CA1CA2CA12CA7CA14
SCHEMBL1446470 0.82 RELA (0.46) CA1CA2CA12CA7CA14
SCHEMBL2010127 0.80 CA1 (0.44) CA1CA2CA12CA7CA14
SCHEMBL1110883 0.79 RELA (0.44) RELAALDH1A1HSD17B10PPARA
SCHEMBL608990 0.78 CA1 (0.61) CA1CA2CA12CA7CA14
SCHEMBL5689488 0.78 CA1 (0.52) CA1CA2CA12CA7CA14
SCHEMBL14173629 0.77 RELA (0.46) RELAALDH1A1HSD17B10PPARAFAAH
SCHEMBL11521699 0.77 RELA (0.46) RELAALDH1A1HSD17B10PPARAFAAH
SCHEMBL5604517 0.77 RELA (0.46) RELAALDH1A1HSD17B10PPARAFAAH
SCHEMBL10559242 0.77 RELA (0.46) RELAALDH1A1HSD17B10PPARAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2496575-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES USEFUL AS MEK INHIBITORS Novartis AG (CH) 2012-09-12 EP disclosed
WO-2011054828-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES USEFUL AS MEK INHIBITORS NOVARTIS AG (CH) 2011-05-12 WO disclosed